Last Updated on December 20, 2020 by The Health Master
Natco Pharma Limited announced the launch of rivaroxaban molecule, under brand Rpigat. Rivaroxaban is an anticoagulant medication used to treat and prevent blood clots.
Rivaroxaban is currently sold by Bayer under brand name of Xarelto, in the lndian market.
After successful previous launches of Dabigat (Dabigatran) and AP IGAT (Apixaban) by Natco, this latest rivaroxaban NOAC (Novel oral anti-coagulant) is in line with our company’s mission of affordable medicines accessible to all.
Natco has launched Rpigat in four strengths- 20 mg, 15 mg, 10 mg and 2.5 mg. The 20 mg strength is priced at an MRP of Rs. 14 per tablet.
Also read | Lupin gets USFDA marketing nod for generic Welchol tablets
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
